newsfilter
← Latest News
GlobeNewswire·

Design Therapeutics to Participate in Leerink's Global Healthcare Conference

CARLSBAD, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that